TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 107 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q3 2015. The put-call ratio across all filers is 1.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $112,000 | -81.2% | 99,000 | -54.2% | 0.00% | -100.0% |
Q3 2018 | $597,000 | -22.7% | 216,337 | 0.0% | 0.00% | -33.3% |
Q2 2018 | $772,000 | +16.3% | 216,337 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $664,000 | -51.3% | 216,337 | 0.0% | 0.00% | -40.0% |
Q4 2017 | $1,363,000 | -1.3% | 216,337 | +7.1% | 0.01% | -16.7% |
Q3 2017 | $1,381,000 | +946.2% | 201,937 | +991.6% | 0.01% | +500.0% |
Q2 2017 | $132,000 | -98.6% | 18,500 | -90.7% | 0.00% | -97.4% |
Q2 2015 | $9,417,000 | +29.5% | 198,511 | 0.0% | 0.04% | +26.7% |
Q1 2015 | $7,273,000 | +44.0% | 198,511 | +56.1% | 0.03% | +50.0% |
Q4 2014 | $5,051,000 | +216.1% | 127,191 | +58.8% | 0.02% | +185.7% |
Q3 2014 | $1,598,000 | – | 80,089 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HARVEY CAPITAL MANAGEMENT INC | 293,675 | $14,061,000 | 4.76% |
BB BIOTECH AG | 1,507,114 | $71,497,000 | 1.94% |
SECTORAL ASSET MANAGEMENT INC | 893,076 | $42,368,000 | 1.77% |
Opaleye Management Inc. | 65,000 | $3,084,000 | 1.23% |
COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT | 390,294 | $18,515,000 | 1.14% |
Granite Point Capital Management, L.P. | 75,206 | $3,568,000 | 1.04% |
Granahan Investment Management | 705,601 | $33,474,000 | 0.95% |
Iguana Healthcare Management, LLC | 50,000 | $2,372,000 | 0.75% |
Eventide Asset Management | 290,000 | $13,758,000 | 0.74% |
Rhenman & Partners Asset Management AB | 107,400 | $5,095,000 | 0.61% |